These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35221703)

  • 21. An Investigator-Blind Randomized Controlled Trial Comparing Effectiveness, Safety of Levocetirizine and Bepotastine in Chronic Urticaria.
    Sil A; Rahaman S; Mondal N; Ahmed SS; Tarafdar D; Patra AC; Roy S; Das NK
    Indian J Dermatol; 2021; 66(5):472-478. PubMed ID: 35068500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open-label prospective clinical study to assess the efficacy of increasing levocetirizine dose up to four times in chronic spontaneous urticaria not controlled with standard dose.
    Sharma VK; Gupta V; Pathak M; Ramam M
    J Dermatolog Treat; 2017 Sep; 28(6):539-543. PubMed ID: 27779432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial.
    Sarkar TK; Sil A; Pal S; Ghosh C; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(5):561-568. PubMed ID: 28656910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study.
    Sinha VV; Kalikar MV; Mukhi JI; Giradkar AB; Sontakke S
    Perspect Clin Res; 2023; 14(4):180-186. PubMed ID: 38025284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of bilastine in reducing pruritus in patients with chronic spontaneous urticaria and other skin diseases: an exploratory study.
    Serra E; Campo C; Novák Z; Majorek-Olechowska B; Pulka G; García-Bea A; Labeaga L
    J Dermatolog Treat; 2020 May; 31(3):270-278. PubMed ID: 30835579
    [No Abstract]   [Full Text] [Related]  

  • 26. Up-dosing with bilastine results in improved effectiveness in cold contact urticaria.
    Krause K; Spohr A; Zuberbier T; Church MK; Maurer M
    Allergy; 2013 Jul; 68(7):921-8. PubMed ID: 23742030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy of levocetirizine, desloratidine and fexofenadine by histamine wheal suppression test.
    Dhanya NB; Thasleem Z; Rai R; Srinivas CR
    Indian J Dermatol Venereol Leprol; 2008; 74(4):361-3. PubMed ID: 18797058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Characteristics of Patients with Chronic Urticaria and Adherence to Management Guidelines by Postgraduate Students in Dermatology: A Retrospective Single Center Study.
    Reddy S; Manchanda I; Godse K; Patil AD
    Indian J Dermatol; 2021; 66(6):705. PubMed ID: 35283531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
    Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
    J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology of antihistamines.
    Church MK; Church DS
    Indian J Dermatol; 2013 May; 58(3):219-24. PubMed ID: 23723474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Efficacy and Safety of High Dose (10 mg) of Desloratadine (Dazit® 10) in the Treatment of Chronic Spontaneous Urticaria in India: A Phase III, Multicentric, Open-Label, Single-Arm Study.
    Kapadia S; Nageswaramma S; Shah K; Singh A; Mahajan SC; Deshpande A; Chakraborty S; Kar BR; Padmaja P; Bharija SC; Doshi M; Ghadge P; Gabhane M; Dharmadhikari S; Mane A; Mehta S
    Cureus; 2024 Jan; 16(1):e53125. PubMed ID: 38420062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sedative Effects of Levocetirizine: A Systematic Review and Meta-Analysis of Randomized Controlled Studies.
    Snidvongs K; Seresirikachorn K; Khattiyawittayakun L; Chitsuthipakorn W
    Drugs; 2017 Feb; 77(2):175-186. PubMed ID: 28070872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers.
    Farré M; Pérez-Mañá C; Papaseit E; Menoyo E; Pérez M; Martin S; Bullich S; Rojas S; Herance JR; Trampal C; Labeaga L; Valiente R
    Br J Clin Pharmacol; 2014 Nov; 78(5):970-80. PubMed ID: 24833043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial.
    Mahatme MS; Dakhale GN; Tadke K; Hiware SK; Dudhgaonkar SD; Wankhede S
    Indian J Pharmacol; 2016; 48(6):649-653. PubMed ID: 28066101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration.
    Horak F; Zieglmayer PU; Zieglmayer R; Kavina A; Lemell P
    Br J Clin Pharmacol; 2005 Jul; 60(1):24-31. PubMed ID: 15963090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of the updosing of second-generation non-sedating H1 antihistamines in children with chronic spontaneous urticaria.
    Sarti L; Barni S; Giovannini M; Liccioli G; Novembre E; Mori F
    Pediatr Allergy Immunol; 2021 Jan; 32(1):153-160. PubMed ID: 32745323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases.
    Novák Z; Yáñez A; Kiss I; Kuna P; Tortajada-Girbés M; Valiente R;
    Pediatr Allergy Immunol; 2016 Aug; 27(5):493-8. PubMed ID: 26918853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilastine: in allergic rhinitis and urticaria.
    Carter NJ
    Drugs; 2012 Jun; 72(9):1257-69. PubMed ID: 22686617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA; Riethuisen JM; Moulaert B; DeVos C
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.